6 курс / Медицинская реабилитация, ЛФК, Спортивная медицина / Нарушения_сна_Белялов_Ф_И_ред_2013

Diagnosis and Treatment of Obstructive Sleep Apnea in Adults. Supplementary Data and Analyses to the Comparative Effectiveness Review of the Agency for Healthcare Research and Quality. 2013. 84 p.

European Medicines Agency. Guideline on medicinal products for the treatment of insomnia. 2011. 21 p.

European Respiratory Society. Non–CPAP therapies in obstructive sleep apnoea // Eur Respir J. – 2011. – Vol. 37. – P. 1000–28.

European Respiratory Society Monograph, Vol. 50. 2010. 423 p.

European Respiratory Society/European Society of Hypertension. Recommendations for the management of patients with obstructive sleep apnoea and hypertension// Eur Respir J. – 2013. – Vol. 41(3). – P. 523–38.

European Society of Hypertension Scientific Newsletter: Hypertension and obstructive sleep apnoea. 2011.

European Society of Hypertension Scientific Newsletter: Hypertension and sleep. 2011.

Institute for Clinical Systems Improvement. Diagnosis and Treatment of Obstructive Sleep Apnea in Adults. 2008. 54 p.

International Classification of Sleep Disorders, revised. 2001. 400 p.

National Institute for Health and Clinical Excellence. Guidance on the use of zaleplon, zolpidem and zopiclone for the short–term management of insomnia. 2004. 27 p.

National Institute for Health and Clinical Excellence. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome. November 2010. 25 p.

Schutte–Rodin S., Broch L., Buysse D., et al. Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults // Journal of Clinical Sleep Medicine. – 2008. – Vol. 4(5). – P. 487–504.

21